ARIAD Chief Executive to Appear On CNBC's "Squawk Box" on March 3, 2000 at Approximately 9:00 AM EST.Business Editors CAMBRIDGE, Mass.--(BUSINESS WIRE)--March 2, 2000 ARIAD ARIAD Allison Research Index of Art and Design Pharmaceuticals, Inc. (Nasdaq: "ARIA") today announced that Harvey J. Berger, M.D., chairman and chief executive officer of ARIAD, is scheduled to appear on CNBC's "Squawk Box Squawk Box A speaker and intercom system used on trading desks. A squawk box allows a firm's analysts and traders to communicate with the firm's brokers through speakers on the brokers' desks. " on Friday, March 3, 2000 at approximately 9:00 am EST EST electroshock therapy. EST abbr. electroshock therapy . He will be interviewed by Mark Haines, the show's host. ARIAD Pharmaceuticals (www.ariad.com) is engaged in the discovery and development of gene-targeted therapeutics based on signal transduction technology. ARIAD is developing gene therapy products, regulated by small-molecule drugs, for protein and cell therapy based on its proprietary gene regulation and gene activation technologies including the ARGENT ar·gent n. 1. Heraldry The metal silver, represented by the color white. 2. Archaic Silver or something resembling it. (TM) and RAPID(TM) systems. The Company also is developing orally administered small-molecule drugs to block intracellular signaling pathways that play a critical role in major diseases, such as osteoporosis and immune-related disorders. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion